Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

HiberCell
619 West 54th Street, 8th Fl
New York, NY 10019
Phone: 212-601-2800
https://www.hibercell.com/

HiberCell is the first company exclusively focused on tumor dormancy detection and therapeutics. The company is developing first-in-class therapeutics that target dormant disseminated tumor cells (DTCs) from solid and liquid cancers, with the ultimate goal of preventing cancer relapse and metastasis.

Key Contact
Name
Alan Rigby, Ph.D.
Title
Co-Founder & President
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
02/07/19 $60,750,000 Series A ARCH Venture Partners
undisclosed


Featured Reading